Eliem Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELYM and other ETFs, options, and stocks.

About ELYM

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. 

CEO
Robert W. Azelby
CEORobert W. Azelby
Employees
19
Employees19
Headquarters
Redmond, Washington
HeadquartersRedmond, Washington
Founded
2018
Founded2018
Employees
19
Employees19

ELYM Key Statistics

Market cap
85.28M
Market cap85.28M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
8.76K
Average volume8.76K
High today
$3.28
High today$3.28
Low today
$3.12
Low today$3.12
Open price
$3.28
Open price$3.28
Volume
2.92K
Volume2.92K
52 Week high
$20.91
52 Week high$20.91
52 Week low
$2.52
52 Week low$2.52

ELYM Earnings

-$3.11
-$2.07
-$1.04
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7
ActualExpected Nov 7
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.